Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javle

Showing results (231-240 of 343) with videos related to

Pageof 35
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 3, 2020
Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancerRichard D Kim, Shannon McDonough, Anthony B El-Khoueiry, et al.
Cancers|February 13, 2025
Defining the Role of Adjuvant Radiotherapy for Biliary Tract Cancers: A Site-Specific Propensity-Matched AnalysisYongwoo David Seo, Belkacem Acidi, Andrew Newton, et al.
Annals of Surgical Oncology|February 25, 2025
Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma: A 27-Year ExperienceAnish J Jain, Mateo Lendoire, Antony Haddad, et al.
Annals of Surgery|July 6, 2019
Radiographic and Serologic Predictors of Pathologic Major Response to Preoperative Therapy for Pancreatic CancerGiampaolo Perri, Laura Prakash, Huamin Wang, et al.
Acta Oncologica (Stockholm, Sweden)|January 23, 2015
Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancerAwalpreet S Chadha, Esengul Kocak-Uzel, Prajnan Das, et al.
Investigational New Drugs|May 23, 2018
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancerR S Finn, D H Ahn, M M Javle, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2018
Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With ImmunotherapyChristine M Parseghian, Madhavi Patnana, Priya Bhosale, et al.
Annals of Surgical Oncology|March 25, 2025
ASO Visual Abstract: Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma-A 27-Year ExperienceAnish J Jain, Mateo Lendoire, Antony Haddad, et al.
Oncotarget|February 9, 2013
Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trialsIshwaria M Subbiah, Vivek Subbiah, Apostolia M Tsimberidou, et al.
Nature Medicine|May 27, 2014
The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinomaChen Liu, Rachid Karam, YingQi Zhou, et al.
Pageof 35

Showing results (231-240 of 343) with videos related to

Sort By:
Pageof 35
European Journal of Cancer (Oxford, England : 1990)|April 3, 2020
Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancerRichard D Kim, Shannon McDonough, Anthony B El-Khoueiry, et al.
Cancers|February 13, 2025
Defining the Role of Adjuvant Radiotherapy for Biliary Tract Cancers: A Site-Specific Propensity-Matched AnalysisYongwoo David Seo, Belkacem Acidi, Andrew Newton, et al.
Annals of Surgical Oncology|February 25, 2025
Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma: A 27-Year ExperienceAnish J Jain, Mateo Lendoire, Antony Haddad, et al.
Annals of Surgery|July 6, 2019
Radiographic and Serologic Predictors of Pathologic Major Response to Preoperative Therapy for Pancreatic CancerGiampaolo Perri, Laura Prakash, Huamin Wang, et al.
Acta Oncologica (Stockholm, Sweden)|January 23, 2015
Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancerAwalpreet S Chadha, Esengul Kocak-Uzel, Prajnan Das, et al.
Investigational New Drugs|May 23, 2018
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancerR S Finn, D H Ahn, M M Javle, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2018
Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With ImmunotherapyChristine M Parseghian, Madhavi Patnana, Priya Bhosale, et al.
Annals of Surgical Oncology|March 25, 2025
ASO Visual Abstract: Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma-A 27-Year ExperienceAnish J Jain, Mateo Lendoire, Antony Haddad, et al.
Oncotarget|February 9, 2013
Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trialsIshwaria M Subbiah, Vivek Subbiah, Apostolia M Tsimberidou, et al.
Nature Medicine|May 27, 2014
The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinomaChen Liu, Rachid Karam, YingQi Zhou, et al.
Pageof 35